Delivery Order SPE2DB22D9367-SPE2DB25FSZ43
- Not listed
- On August 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $32,499.90 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge, IL. This award represents a firm fixed-price delivery order under the company's larger Indefinite Delivery Contract with the DLA, valued...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on August 14, 2025, with an ultimate completion date of September 5, 2025, carries a firm fixed-price arrangement with no set-aside designation. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a $32,499.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 7, 2025, for the supply of Stelara 90 mg/mL syringes. The contract, which carries no set-aside designation, is scheduled for completion by August 28, 2025, with performance conducted at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has been registered in the System for Award...
- The Defense Logistics Agency (DLA) awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 22, 2025, for the supply of Stelara 90 mg/ml syringes. The award carries an ultimate completion date of August 12, 2025, and involves no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order falls under the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for Stelara 90 mg/ml syringes with a ceiling value of $64,999.80. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499,999,999 and effective through November 2026. The award carries...
- On August 1, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, which is scheduled for completion by August 22, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor on this award. The delivery order is...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 for Stelara 90mg/ml syringes by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. The delivery order, which carries no set-aside designation, is scheduled for completion by August 11, 2025, with performance at the contractor's Park Ridge, Illinois location. This award represents a single...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 on August 19, 2025, for the supply of Stelara 90 mg/ml syringes. The delivery order, which carries a firm fixed price and is not subject to any set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and must be completed by September 10, 2025. This award represents a single delivery order...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Stelara 90 mg/ml syringes on July 22, 2025, with an ultimate completion date of August 12, 2025. This delivery order was issued without a set-aside designation and will be performed in Park Ridge, Illinois, where the vendor is headquartered. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is the prime contractor on this award. This delivery...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSZ43Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $64,999.80 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, represents a specific product fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, holds a significant single-award IDC valued at $499,999,999 and valid through November 2026 under the SPE2DB program, which enables DLA to issue delivery orders for comprehensive pharmaceutical products supporting Department of Defense medical supply needs. This award carries no set-aside designation. Stelara is a biologic medication commonly used in the treatment of immunological conditions and is part of the extensive pharmaceutical product portfolio that DMS Pharmaceutical Group distributes to military health facilities nationwide. The company's consistent success in securing federal pharmaceutical supply contracts demonstrates its established capability as a critical supplier within the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and biologics to Department of Defense healthcare sites worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $65.0k | 8/27/25 |